John Allen

John Allen, PhD, focuses on the etiology and treatment of mood and anxiety disorders, with a particular emphasis on identifying risk factors for depression through measures of central and autonomic nervous system function, including EEG, resting-state fMRI connectivity, and cardiac vagal control. His research explores innovative, neurally-informed treatments, such as Transcranial Ultrasound, EEG biofeedback, and Transcranial Direct and Alternating Current Stimulation. Dr. Allen’s recent work centers on two key areas: using transcranial ultrasound to enhance emotional well-being and developing guided psilocybin experiences to modify brain network activity and improve outcomes in obsessive-compulsive disorder. He holds joint appointments in Cognitive Science and Neuroscience, reflecting the interdisciplinary nature of his research.